Wegovy

On Friday, the NOVO Nordisk obesity medication was eliminated on Friday by American regulators to treat an increasingly common liver disease, adding to the list of the conditions for which the therapy with superproduction is now approved. Food and Drug Administration has granted accelerated approval to Wegovy for patients with steatohepatitis associated with metabolic dysfunction, […]